# DESCRIPTION

## FIELD OF THE INVENTION

- relate gene expression marker sets to Alzheimer's disease progression

## BACKGROUND OF THE INVENTION

- describe normal brain aging
- discuss Alzheimer's disease pathology and research goals

## SUMMARY OF THE INVENTION

- introduce biomarkers and signature scores for Alzheimer's disease diagnosis and monitoring

## DETAILED DESCRIPTION OF THE INVENTION

- profile microarray gene expression

### DEFINITIONS

- define Alzheimer's disease
- define normal or non-demented
- define biomarker
- define gene signature or signature score
- define measuring expression levels
- define average gene expression
- define classifier
- define sample and subject
- define systemic and localized brain changes
- motivate biomarker analysis
- summarize brain transcriptome modules
- describe systemic and localized molecular changes in AD
- introduce Alzheimer disease progression model
- propose aging trajectories
- model aging as molecular transitions
- project human aging into animal models
- detect brain signatures in peripheral tissues

## EXAMPLES

- introduce study population and sample collection

### Example 1

- describe sample collection and handling

### Example 2

- describe gene expression profiling

### Example 3

- describe data analysis

### Example 4

- describe biomarker scoring

### Example 5

- describe in silico experiments

### Example 6

- describe projection of human gene signatures in animal models

### Example 7

- describe detection of human brain gene signatures in peripheral tissues

